29 October 2021 - Deborah Wilkes
Premium
Novartis has launched a strategic review of its Sandoz generics division, including its OTC operations, with options ranging from “retaining the business to separation”.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.